Legend Biotech (LEGN) Net Margin (2019 - 2025)
Historic Net Margin for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to 14.12%.
- Legend Biotech's Net Margin rose 641000.0% to 14.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 4000.0%. This contributed to the annual value of 0.03% for FY2024, which is 1500.0% up from last year.
- As of Q3 2025, Legend Biotech's Net Margin stood at 14.12%, which was up 641000.0% from 48.7% recorded in Q2 2025.
- Legend Biotech's Net Margin's 5-year high stood at 0.0% during Q4 2024, with a 5-year trough of 1614.13% in Q2 2022.
- Moreover, its 5-year median value for Net Margin was 106.76% (2024), whereas its average is 260.99%.
- Its Net Margin has fluctuated over the past 5 years, first crashed by -11614900bps in 2022, then surged by 13425800bps in 2023.
- Quarter analysis of 5 years shows Legend Biotech's Net Margin stood at 226.53% in 2021, then tumbled by -117bps to 491.72% in 2022, then skyrocketed by 100bps to 0.0% in 2023, then surged by 108bps to 0.0% in 2024, then tumbled by -100211821bps to 14.12% in 2025.
- Its Net Margin stands at 14.12% for Q3 2025, versus 48.7% for Q2 2025 and 51.74% for Q1 2025.